Abelacimab slashes bleeding risk by 67 percent in people with A-Fib
By
Kristen Fischer
Nov 14, 2023
Abelacimab, an experimental anti-clotting drug, was effective at lowering bleeding in people with atrial fibrillation (A-Fib) who were at risk of having a stroke compared with a competing drug, according...
Medication associated with fewer hospitalization days
Dec 02, 2014
XARELTO is associated with fewer hospitalization days and outpatient visits compared to warfarin in patients with non-valvular atrial fibrillation, according to data presented at the American Heart Association...
Xarelto may be alternative for cancer patients with VTE
Sep 30, 2014
Patients with cancer who have had venous thromboembolism may have lower risk of bleeding with XARELTO® (rivaroxaban) , a study in Lancet Haematology suggests
XARELTO safe for use with elderly, study finds
Jun 17, 2014
XARELTO® (rivaroxaban) is safe to use in elderly patients with nonvalvular atrial fibrillation, an analysis published in Circulation finds.